Global Peptic Ulcer Drugs Market Research Report
Latest
industry research report on: Global Peptic Ulcer Drugs Market |
Industry Size, Share, Research, Reviews, Analysis, Strategies,
Demand, Growth, Segmentation, Parameters, Forecasts
Peptic ulcer disease represents
a group of ulcerative disorders such as gastritis, gastric ulcers,
and duodenal ulcers or gastroesophageal reflux disease (GERD).
Treatment of peptic ulcers is achieved through drugs such as proton
pump inhibitors (PPI), potassium-competitive acid blockers (P-CAB),
antacid, H2-antagonist, antibiotics, and ulcer protective drugs such
as sucralfate. Increasing usage of non-steroidal anti-inflammatory
drugs such as aspirin due to increasing inflammatory conditions is
the major factor driving the growth of the global peptic
ulcer drugs market.
However, side effects of long-term use of PPIs, changing government
policies, loss of market exclusivity of a majority of peptic ulcer
drugs, and limited R&D efforts in the field of peptic ulcer drugs
are factors expected to hamper the growth of peptic ulcer drugs
market, globally.
The
peptic ulcer drugs market is segmented as follows:
- By Product Type
- By Disease Indication
- By Distribution Channels
- By Region
This
report covers the global peptic ulcer drugs market performance in
terms of revenue contribution. The report includes key trends,
drivers, restraints, and opportunities influencing the growth of the
global peptic ulcer drugs market over the forecast period. Impact
analysis of key growth drivers and restraints, based on the weighted
average model, are included to provide clients with crystal clear
decision-making insights.
Based
on product type, the global peptic ulcer drugs market is segmented
into proton pump inhibitors (PPI), potassium-competitive acid
blockers (P-CAB), antacids, ulcer protective drugs, H2-antagonists,
and antibiotics. The PPIs segment is expected to remain the dominant
segment in terms of value during the forecast period.
View Sample PDF @
https://www.marketresearchreports.biz/reports/1287192/global-study-on-peptic-ulcer-market-research-reports.pdf
By disease indication, the global peptic ulcer drugs market is
segmented as gastritis, gastric ulcer, duodenal ulcer or
gastroesophageal reflux disease (GERD). GERD segment is expected to
dominate in terms of market share contribution, accounting for the
maximum share of the overall market by 2022 end; whereas revenue from
gastric ulcer segment is projected to expand at highest CAGR of
during the forecast period.
On the basis of the distribution channel, hospital pharmacies segment
is expected to hold maximum market share in the global market for
peptic ulcer drugs.
By region, the market in North America is expected to lead in the
global peptic ulcer drugs market. In 2014, North America and Europe
collectively accounted for 67% share of overall marker revenue. Asia
Pacific market accounted for 22% share in global peptic ulcer drugs
market and is expected to gain significant market share over the
forecast period, due to increasing recurrence of peptic ulcer
disease. The MEA market is expected to witness sluggish growth during
the forecast period partly due to low accessibility to peptic ulcer
drugs in the region.
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1287192
Key segments covered
- Product Type
- Proton Pump Inhibitors (PPIs)
- Potassium-Competitive Acid Blockers
- Antacids
- H2-antagonists
- Antibiotics
- Ulcer Protective Drugs
- Disease Indication
- Gastritis
- Gastric Ulcer
- Duodenal Ulcer
- Gastroesophageal Reflux Disease (GERD)
- Distribution Channel
- Hospital Pharmacies
- Private Clinics
- Drug Stores
- Retail Pharmacies
- e-Commerce
Key Regions/Countries
Covered
Key features included in
this report
- Drivers and restraints of the peptic ulcer drugs market
- Pipeline analysis and key developments in the market
- Analysis of business strategies of key players
- Peptic ulcer drugs market estimates and forecast
Key market players covered
in this report include:
- Daewoong Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited.
- Pfizer Inc.
- Abbott Laboratories.
- AstraZeneca Plc.
- Cadila Healthcare Ltd.
- Boehringer Ingelheim GmbH.
- Eisai Co. Ltd.
- Yuhan Corporation.
- GlaxoSmithKline Pharmaceuticals Ltd.
- Other.
These companies are focusing
more on Asia-Pacific region, especially China and Japan due to high
market potential attributed to growing disease prevalence.
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment